Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.
Fox
J
J
NPS Pharmaceuticals, Salt Lake City, UT 84108, USA. jfox@npsp.com
Miller
M A
MA
Recker
R R
RR
Bare
S P
SP
Smith
S Y
SY
Moreau
I
I
D000368:Aged; D001846:Bone Development / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000473:pathology*; D005260:Female; D006801:Humans; D007085:Ilium / Q000473:pathology*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000473:pathology*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D010281:Parathyroid Hormone